Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 2 Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis
Sponsor: Aperta Biosciences, LLC
Summary
The purpose of this study is to establish the clinical efficacy of APT-001 topical therapy 1.8% in patients with blepharitis as compared to placebo, and to establish that the therapeutic is safe and generally well tolerated by patients.
Official title: Vision and Inflammation Study Testing Anti-acarid Therapeutics (VISTA-1X): A Phase 2, Open-Label, Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Adults With Blepharitis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2026-12
Completion Date
2027-02
Last Updated
2026-10-30
Healthy Volunteers
No
Conditions
Interventions
APT-001 topical ophthalmic ointment (spinosad)
APT-001 topical ophthalmic ointment (spinosad), administered once
Placebo control for APT-001 topical ophthalmic ointment
Placebo control for APT-001 topical ophthalmic ointment, administered once
Locations (2)
EyeScan, Imágenes Diagnósticas Oculares, S. A.
Guatemala City, Guatemala
Hospital de Día, Clínica de Ojos Doctor Gutiérrez
Guatemala City, Guatemala